secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPT Therapeutics, Inc. (—)
CIK:        0001673772
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0000950170-25-078341
Event type: other
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

RAPT Therapeutics receives Nasdaq bid price deficiency notice; plans reverse stock split
--------------------------------------------------------------------------------

- Received Nasdaq notice on May 21, 2025: average closing bid price below $1.00 for 30 consecutive days.
- Has 180 days (until November 17, 2025) to cure by closing at $1.00 for 10 consecutive business days.
- Board approved 1-for-8 reverse stock split; stockholders vote on May 29, 2025 annual meeting.
- If not cured, may transfer to Nasdaq Capital Market or face delisting; appeal to Panel possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1673772/000095017025078341/0000950170-25-078341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1673772/000095017025078341/rapt-20250521.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-078341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer